SOURCE: CISION PR Newswire
CDI Labs Launches Technology Access Program for Custom PhIP-Seq Libraries for Massively Multiplexed Analysis of Serum AntibodiesNew Custom Offering Expands Researcher Access to CDI Labs’ Phage Display Immunoprecipitation Sequencing (PhIP-Seq) Services for High-throughput Seromic Analysis
READ MORESOURCE: Pharma Boardroom
Interview on Pharma Boardroom with Dr. Ignacio Pino – Co-Founder and COO, CDI LabsDr. Ignacio Pino, Co-founder and COO at CDI Labs, shares his inspiring journey and the visionary mission behind establishing CDI Labs.
READ MORESOURCE: CDI Labs Grant Program 2024
Dr. Donald Vinh at McGill University Health Science Centre Selected as the Winner of CDI Labs Grant Program 2024 READ MORESOURCE: The Washington Post
Why does it feel like everyone has an autoimmune disease?Autoimmune diseases are rising worldwide, and it’s not purely explained by genetics.
READ MORESOURCE: CISION PR Newswire
CDI Labs Launches New VirScan, HuScan, and MouseScan Services for Massively Multiplexed Analysis of Serum AntibodiesNew Services Use Phage Display Immunoprecipitation Sequencing (PhIP-Seq) to Provide Groundbreaking High-throughput, Proteome-wide Seromic Analysis
READ MORESOURCE: CISION PR Newswire
Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories READ MORESOURCE: CISION PR Newswire
BroadOak Capital Partners Invests in CDI Laboratories to Expand and Scale Antibody Biomarker Discovery PlatformsThe investment will support the expansion of CD's technology platforms to service more customers.
READ MORESOURCE: CISION PR Newswire
CDI Labs HuProt™ Protein Arrays Instrumental in Recent Study of Multisystem Inflammatory Syndrome in Children (MIS-C)Proteomics company CDI Laboratories products used in important study of MIS-C and its relationship to SARS-CoV-2 (COVID-19) infection.
READ MORESOURCE: CISION PR Newswire
CDI Labs Launches Two New Powerful Assays to its Biomarker Discovery PlatformProteomics company CDI adds HuScan™ (PhIP-Seq patient biomarker discovery platform) and VirScan™ (PhIP-Seq antibody detection assays that includes every known human and viral protein).
READ MORESOURCE: CISION PR Newswire
CDI Labs to showcase immuno-oncology products & services at AACR 2019 READ MORE1
2